Resource Summary

Clinical Question:
In patients at higher risk of contracting HIV^ can daily antiviral therapy prevent infection?

Bottom-line:
Tenofovir/emtricitabine (PrEP) once daily reduces the risk of HIV by -50 percent^ preventing infection for -1 in 50 per year. A year of therapy costs -$12^000 and -1 in 34 develop nausea/vomiting due to the drug.

https://www.acfp.ca/tools-for-practice/

Publication Date: 2016-8-29
Last Updated on PCR: 2017-03-31 13:41:57